Presented to a business leader or a management team who has significantly advanced their Scottish business in the previous year (ending November 2024).

This is open to: Leaders of established businesses that can demonstrate significant growth through financing, exporting, partnerships, collaborations, inward investment, and achievement of milestones.

THE JUDGING PANEL WILL GIVE CONSIDERATION TO:

• Level of leadership, ambition, and entrepreneurship
• Commercial success (e.g., turnover; deals done; collaborations established, investment raised to date)
• Growth of company – significant activity that has contributed to growth (e.g., specific investment, launch of product, expansion)
• Growth in global markets through international strategy
• Investment secured.
• Adoption of digitalisation to enable growth of operations.
• Adoption of any new processes to reduce carbon emissions.
• Understanding customers’ needs
• Development of a management team
• Demonstration of sustainable production
• Made a difference to the growth of the life science sector in Scotland.
• Made a difference to the growth of the life science sector Internationally

Presented to a business leader or management
team that has significantly advanced a Scottish
life sciences business during the previous year,
ending December 2026.

This award is open to leaders or management
teams of established life sciences businesses
that can demonstrate significant growth through
areas such as financing, exporting, partnerships
and collaborations, inward investment, or the
achievement of key business milestones.

THE JUDGING PANEL WILL GIVE CONSIDERATION TO:

• The level of leadership, ambition and
  entrepreneurship demonstrated
• Evidence of commercial success and
  business growth
• Significant milestones achieved during the
  judging period
• Investment secured and the impact this
  has had on the business
• Evidence of sustainable business
  practices, including actions to reduce
  environmental impact or improve long-
  term sustainability
• Evidence of understanding and responding
  to customer needs
• Growth in UK and/or international
  markets, where relevant
• The use of innovation, digitalisation or new
  ways of working to support growth
• Development of the wider management
  team and organisational capability
• The measurable impact of the leader or
  management team on the business
• Contribution to the growth and strength of
  Scotland’s life sciences sector

This award is open to founders, co-founders or
leaders of a start-up or early-stage life sciences
business that demonstrates significant potential
for growth and future international success.
This should be evidenced through areas such as
customer and/or market engagement, building a
diverse and skilled team, attracting investment
and achieving key business milestones.

THE JUDGING PANEL WILL GIVE CONSIDERATION TO:

• The level of leadership, ambition and
  entrepreneurship demonstrated
• Evidence of commercial traction and
  business growth
• Progress against key business milestones
• Customer and/or market engagement
• Investment secured and the impact this
  has had on the business
• The level of innovation demonstrated
• Evidence of sustainable business practices
  or approaches
• The potential for UK and/or international
  growth
• The measurable impact of the nominee on
  the development of the business
• Contribution to the growth and strength of
  Scotland’s life sciences sector
• The strength and development of the
  wider team

This award is open to companies based in
Scotland that can demonstrate excellence in skills development and a significant, sustainable contribution to building capability within their organisation.

Entries should provide evidence of the positive business outcomes achieved as a result of investment in training, development and workforce capability.

THE JUDGING PANEL WILL GIVE CONSIDERATION TO: 

• The quality and relevance of the skills development approach
• Evidence that development needs have been clearly identified and addressed
• The level of innovation demonstrated in the programme or initiative
• Accessibility and employee engagement in learning and development
• Investment in building long-term
  workforce capability
• Evidence of career progression and
  development opportunities
• Measurable impact on employee
  capability, performance or engagement
• Positive business outcomes resulting from the initiative
• The sustainability and scalability of
  the approach
• Evidence of sustainable practices within the delivery or development of the programme
• Potential impact on skills development across Scotland’s life sciences sector

This award is open to organisations that have
been responsible for the development of an
innovative product or service that contributes to
pharmaceutical services and/or drug discovery.

The innovation must have been developed in
Scotland within the last three years and be at
a stage of development where the organisation
is able to publicise and demonstrate its impact
or potential.

THE JUDGING PANEL WILL GIVE CONSIDERATION TO:

• The level of innovation demonstrated
• The ability of the innovation to scale or be applied more widely
• The significance of the problem or opportunity being addressed
• Evidence of sustainable practices within the development or delivery of the
  innovation
• The quality and strength of the product, service, technology or process
• Measurable results or impact achieved to date
• Evidence of progress and development
  achieved
• Commercial potential or evidence of commercial success, where relevant
• Potential contribution to Scotland’s life
  sciences sector and wider UK and/or
  international markets
• The potential impact on pharmaceutical
  services and/or drug discovery

This award is open to an individual or organisation that has been responsible for the development of an innovative product or service within the health data and technology field.

The innovation must have been developed in Scotland within the last three years and be at a stage of development where the organisation is able to publicise and demonstrate its impact or potential.

THE JUDGING PANEL WILL GIVE CONSIDERATION TO:

• The level of innovation demonstrated
• Potential impact on health outcomes,services or the wider life sciences sector
• The significance of the problem or opportunity being addressed
• The ability of the innovation to scale or be applied more widely
• The quality and strength of the product, service, technology or process
• Evidence of sustainable practices within the development or delivery of the innovation
• The effective use of data and advanced technologies, where relevant
• Measurable results or impact achieved to date
• Evidence of progress and development achieved
• Commercial potential or evidence of commercial success, where relevant
• Potential contribution to Scotland’s life sciences sector and wider UK and/or international markets